Novel Biologics and B-Cell Depletion: Fueling IgG4-Related Disease...

agregó una foto Health

2025-12-11 09:52:55 -

Novel Biologics and B-Cell Depletion: Fueling IgG4-Related Disease market growth

The therapeutic segment is a major engine for IgG4-Related Disease market growth, largely driven by the adoption of biologic Product Types. While glucocorticoids remain the cornerstone of initial treatment Standard Protocols, their significant long-term side effects in chronic conditions like IgG4-RD necessitate the use of steroid-sparing agents. Monoclonal...

0 Commentarios 0 Acciones 72 Views 0 Vista previa